Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$434.22 - $551.9 $3.95 Million - $5.02 Million
9,100 Added 23.95%
47,100 $25.5 Million
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $13.5 Million - $17.2 Million
38,000 New
38,000 $16.3 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $3.39 Million - $5.06 Million
10,000 New
10,000 $3.8 Million
Q1 2023

May 15, 2023

BUY
$334.23 - $403.65 $22.1 Million - $26.6 Million
66,000 New
66,000 $24.6 Million
Q2 2022

Aug 15, 2022

SELL
$269.58 - $378.88 $4.04 Million - $5.68 Million
-15,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$254.45 - $351.06 $3.82 Million - $5.27 Million
15,000 New
15,000 $4.73 Million
Q3 2021

Nov 12, 2021

SELL
$295.0 - $350.58 $8.85 Million - $10.5 Million
-30,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$257.11 - $319.92 $7.71 Million - $9.6 Million
30,000 New
30,000 $9.03 Million
Q1 2021

May 17, 2021

SELL
$268.3 - $380.31 $6.71 Million - $9.51 Million
-25,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$248.13 - $308.36 $1.24 Million - $1.54 Million
5,000 Added 25.0%
25,000 $7.35 Million
Q3 2020

Nov 16, 2020

BUY
$215.51 - $272.51 $2.39 Million - $3.02 Million
11,100 Added 124.72%
20,000 $5.25 Million
Q2 2020

Aug 14, 2020

BUY
$127.44 - $232.72 $1.13 Million - $2.07 Million
8,900 New
8,900 $2.01 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.